Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Talis Biomedical Corp changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 35 | 29 | −6 |
| Shares | 14.9M | 12.6M | −2.30M (−15.4%) |
| Value | $12.1M | $8.59M | −$3.51M (−29.0%) |
New holders (6)
Institutions that held Talis Biomedical Corp at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 29,121 | $20.0K | 0.00% |
| Man Group plc | 13,095 | $9.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 4,207 | $3.00K | 0.00% |
| BNP Paribas Arbitrage, SA | 560 | $382 | 0.00% |
| Bogart Wealth, LLC | 175 | $0 | 0.00% |
| Larson Financial Group LLC | 200 | $0 | 0.00% |
Sold out (12)
Institutions that held Talis Biomedical Corp at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Newtyn Management, LLC | 284,726 | $231.0K |
| Citadel Advisors LLC | 42,242 | $34.0K |
| Goldman Sachs Group Inc | 23,242 | $19.0K |
| Virtu Financial LLC | 20,061 | $16.0K |
| Two Sigma Investments, LP | 17,798 | $14.0K |
| M&T Bank Corp | 11,756 | $10.0K |
| Susquehanna International Group, LLP | 12,508 | $10.0K |
| FMR LLC | 1,382 | $1.00K |
| New York State Common Retirement Fund | 175 | $0 |
| Credit Suisse AG | 8 | $0 |
| Citigroup Inc | 134 | $0 |
| First Horizon Advisors, Inc. | 582 | $0 |